Eyenuk Company
Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance. The company's first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for the autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life-and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. The company was founded in 2010 and is based in Los Angeles, California.
.png)
Industry:
AI, Biomarkers for Longevity, United States
Headquarters:
Los Angeles, California, United States
Zip:
11-50
Founded Date:
2010-01-01
Employees Number:
11-50
Funding Status:
Early Stage Venture
Acquisitions Number:
6
Investors Number:
47400000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Series A
Last Funding Type:
info@eyenuk.com
Register and Claim Ownership